PMDA drug package insert

シグニフォーLAR筋注用キット10mg

PMDA Prescription drug · レコルダティ・レア・ディジーズ・ジャパン株式会社 · package insert Jun 19, 2026

Key facts

Brand names シグニフォーLAR筋注用キット10mg, シグニフォーLAR筋注用キット20mg, シグニフォーLAR筋注用キット30mg, シグニフォーLAR筋注用キット40mg, シグニフォーLAR筋注用キット60mg
Nonproprietary names パシレオチドパモ酸塩
Companies 製造販売元/レコルダティ・レア・ディジーズ・ジャパン株式会社
Product type Prescription drug
Therapeutic category 持続性ソマトスタチンアナログマイクロスフェア型徐放性製剤
Therapeutic category codes 872499
YJ codes 2499417G4022, 2499417G1023, 2499417G5029, 2499417G2020, 2499417G3026
Approval numbers 23000AMX00453000, 22800AMX00677000, 23000AMX00454000, 22800AMX00678000, 22800AMX00679000
Package insert edition 第5版
Package insert date Jun 19, 2026
PMDA document key 870276_2499417G1023_2
PMDA company code 870276

At a glance

  • 1–9 Package insert revisions
  • 10–99 Related PMDA documents
  • None Safety communications
  • Yes PMDA review report published
  • Yes Risk management plan (RMP)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMDA approved drugs and package inserts (Japan)

Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date:

Browse all PMDA approved drugs and package inserts (Japan)